Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets

Sunshine Biopharma, Inc. (SBFMW)

NCM

$0.06-0.02 (-30.75%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
P/E (TTM)
EPS
$-2.21
Div Yield
52W Range
$0.06–$0.08
Beta
1.31

Company overview

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Peers in industry

Sunshine Biopharma, Inc. has no peer companies in this window.

Recent press releases

Sunshine Biopharma, Inc. has not issued a press release in this window.

SEC filings

All filings →

Sunshine Biopharma, Inc. has not filed an SEC document in this window.

Sunshine Biopharma, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
22,483 sh-3.9%

People at Sunshine Biopharma, Inc.

All people →

No officers or directors have been indexed for Sunshine Biopharma, Inc..

Quarterly financials

Full financials →
Revenue trend
03/25
$8.9M
NI -$1.2M
06/25
$9.4M
NI -$1.8M
09/25
$9.4M
NI -$883.8K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.19
Prior: $-0.39
Revenue sparkline